Transplant Logistics Leader MediGO Issues Statement Welcoming HRSA Announcement on Organ Procurement and Transplantation Network Modernization Initiative

MediGO, a Baltimore-based digital healthcare supply chain technology company focused on improving equity, access and transparency in the donation and transplant industry, is issuing the following statement in response to the Organ Procurement and Transplantation Network (OPTN ) Modernization Initiative announced by the Health Resources and Services Administration (HRSA), an agency of the United States Department of Health and Human Services (HHS):

MediGO welcomes HRSA’s decision and announcement to modernize its organ donation and transplantation network. With our innovative software solutions designed for organ procurement organizations (OPOs) and transplant centers, we are uniquely positioned to take the donation and transplant community in a new direction while building on our existing efforts to improve transparency, fairness and expand access to life-saving resources. organs.

HRSA has outlined a transformative and holistic approach in its OPTN Modernization Initiative. We believe that MediGO’s solutions play a critical role in achieving HRSA’s goals of enhanced data transparency, monitoring, patient care, quality improvement and innovation. Our platform provides critical functionality needed to not only revolutionize organ transportation, a domain that HRSA has accurately identified, but also play a fundamental role in increasing organ procurement to close the demand gap.

Since our founding in 2020, our vision has been to revolutionize and improve the transplant process to save more lives. Our Vision 2021 paper identified core principles based on providing data transparency to help healthcare teams make informed decisions that improve the number and quality of organs available for transplant.

From organ referral to postoperative follow-up, our solutions, born from collaborative discussions with OPOs and transplant centers, enable care teams to streamline workflows, synchronize communications and drive efficiency throughout the transplant process – reducing healthcare costs and making a positive impact has an impact on the patient. As of today, MediGO shipments have traveled to 34 states and three countries around the world. Our comprehensive solution now manages organ procurement and shipping for approximately 40% of all OPOs, and our innovations have been recognized by Edison Awards, Fast company And Inc. magazine eg.

Also Read:  World Bank Releases Logistics Performance Index 2023

HRSA’s OPTN Modernization Initiative identifies the national transplant system’s need for a comprehensive supply chain orchestration solution. MediGO is perfectly aligned and proven within the donation and transplant network to meet this critical need and remains committed to working with all stakeholders to implement innovations that ultimately lead us to a fairer, more transparent, cost-effective and efficient system that ends waiting for life-saving organs.

Leave a Reply

Your email address will not be published. Required fields are marked *